Gainers
- Portage Biotech PRTG shares rose 86.6% to $9.52 during Friday's regular session. The market value of their outstanding shares is at $15.6 million.
- MSP Recovery MSPR stock moved upwards by 85.15% to $2.37. The company's market cap stands at $5.0 million.
- CeriBell CBLL shares rose 35.78% to $15.14. The company's market cap stands at $543.0 million.
- Regencell Bioscience RGC shares increased by 35.02% to $38.13. The company's market cap stands at $496.1 million.
- Sharps Technology STSS shares moved upwards by 34.42% to $0.02.
- CEL-SCI CVM shares rose 27.88% to $0.27. The company's market cap stands at $22.6 million.
Losers
- Innovative Eyewear LUCY stock fell 53.3% to $2.31 during Friday's regular session. The company's market cap stands at $5.6 million.
- Palatin Techs PTN stock declined by 44.04% to $0.24. The market value of their outstanding shares is at $6.1 million.
- Wellgistics Health WGRX shares declined by 29.45% to $2.76. The market value of their outstanding shares is at $143.2 million.
- Organovo Holdings ONVO stock fell 22.96% to $1.68. The market value of their outstanding shares is at $3.0 million.
- cbdMD YCBD stock declined by 21.52% to $0.22. The company's market cap stands at $1.3 million.
- Reshape Lifesciences RSLS shares declined by 15.96% to $0.48. The market value of their outstanding shares is at $5.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CBLLCeriBell Inc
$15.2536.8%
Edge Rankings
Momentum
-
Growth
-
Quality
-
Value
65.62
Price Trend
Short
Medium
Long
CVMCEL-SCI Corp
$0.306045.1%
LUCYInnovative Eyewear Inc
$2.16-56.4%
MSPRMSP Recovery Inc
$2.57100.8%
ONVOOrganovo Holdings Inc
$1.62-25.7%
PRTGPortage Biotech Inc
$8.8874.1%
PTNPalatin Technologies Inc
$0.1700-59.7%
RGCRegencell Bioscience Holdings Ltd
$35.8026.8%
RSLSReshape Lifesciences Inc
$0.4352-23.2%
STSSSharps Technology Inc
$0.029862.8%
WGRXWellgistics Health Inc
$3.08-21.2%
YCBDcbdMD Inc
$0.2189-21.3%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in